Peripheral nerve injury is a challenging clinical problem due to slow, incomplete regeneration that results in the poor return of function. Polyethylene glycol (PEG) has been studied in the rat sciatic nerve model to immediately restore nerve continuity and prevent Wallerian degeneration. PEG-fusion reestablishes axoplasmic continuity by nonspecifically fusing closely apposed severed axons at the lesion site. In this study we examine if PEGfusion can improve nerve repair in a novel denervation model using serial grip strength testing (GST).
METHODS:
Sprague-dawley rats (n=10) were utilized comparing suture repair alone (n=5) to PEG fusion with suture repair (n=5). In both control and PEG-fusion groups baseline grip strength was first calculated using percutaneous electrical stimulation to the rat forearm followed by GST of the rat paw using a force transducer. Next, bilateral ulnar and median nerves were exposed and divided. In both groups the proximal ulnar nerve was sutured into adjacent bicep muscle. Total nerve discontinuity was confirmed with nerve conduction testing (NCT). In both control and PEG fusion groups the median nerve was repaired using 10-0 nylon sutures. In the PEG-fusion group the nerve ends were first washed with hypotonic Plasmalyte followed by methylene blue prior to neurorrhaphy. PEG was applied for 90 seconds followed by Lactated Ringers solution. Successful PEG-fusion was confirmed using NCT. Follow up GST testing was performed at 7, 14, 21, 28, 35, 42 days under sedation using percutaneous stimulation. Statistics were performed using 2-tailed t-test with Bonferroni correction for multiple comparisons.
RESULTS:
Nerve continuity was reestablished in all PEGfusion animals with NCT demonstrating both restored compound action potentials (CAP) and compound muscle action potentials (CMAP). There was no measurable CAP or CMAP after suture repair alone. The PEG fusion group demonstrated significant (p<0.05) increase in grip strength compared to control at all time points. PEG fusion group showed an average of 54% return to baseline grip strength as early as POD 7. As expected, suture repair alone had minimal return of function at POD 7. Further histologic examination pending. 
CONCLUSION

METHODS: Osteomyocutaneous (OMC) allografts from
Balb/c were transplanted into 34 C57BL/6 mice. Immunosuppressive protocol consisted of 1 mg anti-CD154 (POD 0), 0.5 mg CTLA4Ig (POD 2), and 3mg/kg/day rapamycin for 7 days then reduced to 3mg/kg every other day for 3 weeks. Recipients were organized into 5 groups based on time point of Tregs depletion using anti-CD25 antibody: Group 1 (control), no Tregs depletion (n=10) PURPOSE: 3-D printed bioresorbable scaffolds for craniomaxillofacial bone regeneration can be custom-made to fill specific defects, and can be commercially printed based on CT scans within days. Additional seeding of scaffolds with autologous stem cell populations may enable improved regeneration of normal bony architecture, minimization of donor site morbidity, enhanced ability to restore complicated three-dimensional shapes, and improved functional outcomes. However, the ability of such scaffolds to regenerate load-bearing bone is untested in large animal models.
METHODS:
We developed a craniofacial porcine model of bone regeneration suitable for testing bioengineered custom 3-D printed bone scaffolds to heal non-critical (<6cm) and critical (>6cm) bone defects. Full-thickness defects were made in the body of the right zygoma and angle of the left mandible using 3-D printed custom cutting guides. In the control arm of the study reported here (n=4), no
